Campbell Alliance Landmark Study™
The Oncology National Commercial (ONC) Study: Ten Transformative Trends
The oncology market has changed dramatically over the last 10 years. These changes have been brought about by 10 transformative trends, the effects of which will only intensify in the coming decade. As a result, the environment will become more challenging for oncology-focused pharmaceutical and biotech companies.
Five of these transformative trends relate to oncology pipelines and are leading to intense competition in what was a less competitive field. Five more trends are commercially focused, driving major changes in how oncologists and patients make treatment decisions and in who a pharmaceutical company’s customers actually are. As a result, traditional oncology promotional strategies are becoming misaligned with the new influencers of therapy choice.
To fully understand these 10 trends and help pharmaceutical and biotech leaders determine how to address them, Campbell Alliance conducted the ONC Study. Our team interviewed a range of decision makers from pharmaceutical and biotech companies and national and regional payer organizations, as well as oncologists and oncology key opinion leaders. In addition, our team conducted a significant amount of secondary research and analyses based on our years of experience in the oncology market.
To download a white paper summarizing the study, click here.
To request that a Campbell Alliance team member present the full study results to your organization and discuss its implications for your business, click here.
Vice President, Marketing
(919) 844-7100, x7195